<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic Melanoma.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic Melanoma." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309853/bin/ActaDV-100-18-5896-g001.jpg"/> </div> <div class="text-side"> <h1>Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic Melanoma.</h1> <p>Case reports. (a–c) Case 1. (a) Routine histopathology with haematoxylin and eosin (H&amp;E) staining (40×): Subepidermal blistering with numerous eosinophils and fibrinoid precipitation in the blister cavity. (b) Close-up (200×) view; H&amp;E. (c) Linear reactivity of collagen IV along the basement membrane zone (BMZ) (arrows) at the floor of the blister cavity (immunohistochemistry, anti-collagen IV). (d–f) Case 2. (d) Routine histopathology (40×) with subepidermal blistering and eosinophils in the blister cavity. (e) Close-up (200×). (f) Positive labelling of collagen IV along the BMZ (arrows) at the floor of the blister cavity for Case 2 (immunohistochemistry, anti-collagen IV). (g–i) Case 3. (g) Routine histopathology (40×) with subepidermal blistering and eosinophils in the blister cavity. (h) Close up (200×) view. (i) Positive labelling of collagen IV along the BMZ (arrows) at the floor of the blister cavity for Case 3 (immunohistochemistry, anti-collagen IV).</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32985676/" target="_blank">32985676</a></p><p>Type: Premalignant/Malignant, Category: Melanocytic</p>
</div> </div></div></body></html>